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Abstract
Background—Illegal drug markets are shaped by multiple forces, including local actors and 
broader economic, political, social, and criminal justice systems that intertwine to impact health 
and social wellbeing. Ethnographic analyses that interrogate multiple dimensions of drug markets 
may offer both applied and theoretical insights into drug use, particularly in developing nations 
where new markets and local patterns of use traditionally have not been well understood. This 
paper explores the emergent drug market in Kisumu, western Kenya, where our research team 
recently documented evidence of injection drug use.
Methods—Our exploratory study of injection drug use was conducted in Kisumu from 
2013-2014. We draw on 151 surveys, 29 in-depth interviews, and 8 months of ethnographic 
fieldwork to describe the drug market from the perspective of injectors, focusing on their 
perceptions of the market and reports of drug use therein.
Results—Injectors described a dynamic market in which the availability of drugs and 
proliferation of injection drug use have taken on growing importance in Kisumu. In addition to 
reports of white and brown forms of heroin and concerns about drug adulteration in the market, we 
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unexpectedly documented widespread perceptions of cocaine availability and injection in Kisumu. 
Examining price data and socio-pharmacological experiences of cocaine injection left us with 
unconfirmed evidence of its existence, but opened further possibilities about how the chaos of new 
drug markets and diffusion of injection-related beliefs and practices may lend insight into the 
sociopolitical context of western Kenya.
Conclusions—We suggest a need for expanded drug surveillance, education and programming 
responsive to local conditions, and further ethnographic inquiry into the social meanings of 
emergent drug markets in Kenya and across sub-Saharan Africa.
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drug markets; drug trafficking; heroin; cocaine; sub-Saharan Africa; Kenya
Illegal drug markets are shaped by multiple forces, including local actors and broader 
economic, political, social, and criminal justice systems that intertwine to impact health and 
social wellbeing (Hoffer, Bobashev, & Morris, 2009). While the material dimensions of drug 
markets including drug availability, formulation, price, and purity create risk for health 
harms such as HIV, Hepatitis C, and fatal overdose (Ciccarone, 2005; Ciccarone & 
Bourgois, 2003; Koester, Glanz, & Barón, 2005), the social dimensions of drug markets also 
shape and reflect the broader cultural and sociopolitical contexts in which these markets 
operate (Fitzgerald, 2005). Ethnographic analyses that interrogate multiple dimensions of 
drug markets may offer both applied and theoretical insights into drug use, particularly in 
developing nations where emergent markets and local patterns of use traditionally have not 
been well understood.
Across sub-Saharan Africa, the legal trade of commodities has long flourished on well-
established trade routes (Carrier & Klantschnig, 2012). In the 1970s and 1980s, economic 
crisis and structural adjustment programs negatively impacted livelihoods across the 
continent, and small scale drug trade began to open up as an alternative or in addition to the 
legal trade along these routes (Carrier & Klantschnig, 2012). International airport and sea 
links, weak law enforcement, corruption, expansion of telecommunication and global 
financing, and increased connectivity in global commerce networks have strengthened drug 
trafficking across sub-Saharan Africa over time (Needle, Kroeger, Belani, & Hegle, 2006). 
Since the 1980s and 1990s, trafficking of South American cocaine through West Africa and 
Asian heroin through East Africa has intensified to meet demand in European markets 
(Adelekan, 1996; Mbwambo et al., 2012). While early research pointed to such increasing 
trafficking patterns and indications of heroin and cocaine availability across the region, data 
have historically been limited on the extent and modes of local drug consumption 
(Adelekan, 1998; Adelekan & Stimson, 1997).
In East Africa, the recent proliferation of heroin markets represent an extension of historical 
economic and cultural ties between countries bordering the Indian Ocean (Beckerleg, Telfer, 
& Hundt, 2005). In major hub cities in Tanzania and Kenya, factors such as theft, courier 
payment in drugs, demand from tourists in coastal resort areas, and other forms of drug 
“spillover” have reportedly fomented local heroin markets (Beckerleg & Hundt, 2004; 
Beckerleg et al., 2005; McCurdy, Ross, Kilonzo, Leshabari, & Williams, 2006). In Kenya, 
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“brown sugar” heroin emerged on the coast in the 1980s, reportedly supplied first through 
the Golden Triangle and later Pakistan (Beckerleg et al., 2005). In general, coarse brown 
heroin has good heat stability but is not water soluble unless acid is added, which 
complicates its preparation for injection (Ciccarone, 2009). As such, “brown sugar” was 
typically sniffed or chased (heated on foil and its vapors inhaled) or smoked in joints with 
marijuana as a “cocktail” (Beckerleg, 1995) and sometimes mixed with caffeine or mandrax, 
a barbiturate (Beckerleg, Telfer, & Sizi, 1996). However, the drug market shifted in the late 
1990s when “brown sugar” heroin was replaced by “white crest” heroin, which users in 
Kenya believed to be from Thailand (Beckerleg et al., 2005). However, this new form of 
white powdered heroin originated in Afghanistan, and was so pure that it precipitated a shift 
to injecting in Kenya and Tanzanian markets because it did not require complicated 
preparation or heating processes (Beckerleg et al., 2005; McCurdy & Maruyama, 2013; 
McCurdy et al., 2006; McCurdy, Williams, Kilonzo, Ross, & Leshabari, 2005). Indicators 
suggest that availability of heroin has remained unabated in the region: since 2009, seizures 
of heroin in East Africa increased almost 10-fold, potentially rendering this the largest 
trafficking hub for heroin in Africa (International Narcotics Control Board, 2014; UNODC, 
2013a, 2013b). Although it is difficult to quantify, nearly 22 tons of heroin is reportedly 
smuggled through East Africa annually, including the estimated 2.5 tons of heroin currently 
consumed in local markets, worth $160 million (International Narcotics Control Board, 
2014).
Indeed, a growing body of scholarship has documented that heroin injection is a significant 
health and social concern in East Africa (Beckerleg et al., 2005; Brodish et al., 2011; 
Deveau, Levine, & Beckerleg, 2006; Dewing, Pluddemann, Myers, & Parry, 2006; Guise, 
Dimova, Ndimbii, Clark, & Rhodes, 2015; Kurth et al., 2015; Matiko et al., 2014; McCurdy 
et al., 2006; McCurdy et al., 2005; Rhodes et al., 2015b; Strathdee et al., 2010; Tun et al., 
2015). Recognition of the high HIV prevalence among heroin injectors underscored efforts 
to launch East Africa’s first harm reduction programs (Nyandindi et al., 2014), including 
establishing methadone clinics in Tanzania in 2010 (Lambdin et al., 2013; McCurdy, 
Kilonzo, Williams, & Kaaya, 2007). Starting in 2013, Nairobi and coastal locations in Kenya 
followed suit, gradually introducing needle exchange and methadone as part of a new public 
health approach to combat addiction (Guise, Tim, Ndimbii, & Ayon, 2015; NASCOP, 2013; 
Rhodes et al., 2015a).
Within this context, in 2013 we partnered with Impact Research & Development 
Organization (IRDO), a Kenyan non-governmental organization (NGO), to conduct the first 
study of injection drug use in the western Nyanza region of Kenya. Little research has been 
undertaken outside larger cities and transport hubs in the region, despite indications that 
drug markets may be expanding into rural and developing areas (NASCOP, 2013). Nyanza’s 
main city of Kisumu (population ~400,000) is currently undergoing rapid investment in 
infrastructure and new construction. Kisumu largely lacks the tourism economy found 
elsewhere in Kenya, but is better known for its large presence of foreign donors, NGOs, and 
health programs (Prince, 2013) and as a site of seminal HIV clinical trials (Baeten et al., 
2012; Bailey et al., 2007). The Nyanza region has the highest HIV prevalence in Kenya, with 
prevalence in Kisumu County reaching 18.7% (NASCOP, 2014). Drug use in western Kenya 
is hidden, criminalized, and stigmatized, if acknowledged at all. There is only one drug 
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treatment facility in Nyanza, located two hours from Kisumu and financially out of reach for 
much of the population.
When the current research began, IRDO had recently launched the first program in Kisumu 
for people who inject drugs, which uses peer educators to identify and recruit injectors for 
HIV testing and drug counseling. Our research partnership was designed to collect 
quantitative and qualitative data on injection drug use patterns and identify related health 
concerns in order to inform service provision. Although we approached this work 
anticipating to document the heroin injection that dominates public health discourse, our 
inductive research approach led us down an alternative path. The first day that the PI (JLS) 
set out with the NGO’s peer educators to conduct street outreach, one told her about how 
injectors sometimes “take a nap after injecting cocaine.” Both the mention of cocaine 
injection and its symptomology were a surprise, and further conversations in the field around 
cocaine were then systematically studied by the research team using a survey and in-depth 
qualitative interviews that asked about the drug market and multiple categories of injected 
drugs in Kisumu. Thus, our ethnographic study design enabled us to take a broad perspective 
of a heretofore unstudied drug market in sub-Saharan Africa.
This paper provides a descriptive analysis of Kisumu’s drug market from the perspective of 
people who inject drugs, focusing on their perceptions of the market and reports of drug use 
therein. Specifically, we explore market characteristics, locally shared socio-
pharmacological experiences of drug injection, and the motivations and social contexts of 
use that drive demand within a newly emerging market. While we suggest the possibility 
that drugs beyond heroin may be circulating in Kenya, a broader goal of our analysis is to 
theorize how the chaos of new drug markets might lend deeper insight into the sociopolitical 
context of western Kenya and similarly developing regions across the continent.
Methods
Data collection for our study occurred between July 2013 and July 2014. During this period, 
the PI undertook nearly 8 months of ethnographic fieldwork in Kisumu, including 
participant observation in daily NGO activities, visiting fieldsites with the peer educators, 
and holding informal interviews and conversations with injectors, which were recorded as 
daily fieldnotes. With the help of two Kenyan Research Assistants (one female and one 
male), the research team worked with peer educators to use targeted and snowball sampling 
to recruit study participants for surveys and in-depth qualitative interviews. Eligibility 
criteria included being at least 18 years old, reporting injecting drugs at least once in the 
prior month, and having physical evidence of injection. Eligible participants provided 
written consent for surveys and qualitative interviews conducted in English, Swahili, or Luo, 
based on participants’ preference, and were reimbursed 300 Kenyan shillings (~U.S. $4) per 
interview. Protocols were approved by the Institutional Review Boards of the University of 
California, San Diego, the Kenya Medical Research Institute, and the Ohio State University.
We conducted interview-administered surveys on laptops using REDCap software with 151 
injectors. Surveys were conducted in the office or the field and lasted about one hour. 
Surveys covered socio-demographics, sexual behaviors, alcohol and drug use, and injection 
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risk behaviors. We used purposive sampling (Johnson, 1990) based on gender and reported 
drug use (e.g., heroin and cocaine) to recruit a sub-sample of 29 participants for qualitative 
interviews to gain further insight into local patterns of injection drug use, including 
perceptions of the drug market in Kisumu. These qualitative interviews, lasting one to two 
hours, were conducted in a private office space and were recorded, transcribed, and 
translated according to a structured protocol (McLellan, MacQueen, & Neidig, 2003). In 29 
interviews, we identified consistent patterns pertaining to our primary topics of interest and 
determined that we had reached saturation, or empirical confidence that the sample size was 
sufficient to cover themes of interest (Guest, Bunce, & Johnson, 2006). In general, 
interviewers were gender-matched with participants; the PI also conducted surveys and 
qualitative interviews with English speaking participants when possible.
We employed a collaborative approach to an inductive data analysis process that included 
constructing a codebook that the PI and a Research Assistant used to code all transcripts; the 
PI additionally coded her fieldnotes for themes related to the drug market. The current 
analysis uses a mixed methods, explanatory design that primarily draws from the richness of 
the 29 semi-structured interviews and PI’s fieldnotes to expand and contextualize survey 
findings related to the local drug market and patterns of injection drugs use. Representative 
quotes illustrating major themes are presented below. All names are pseudonyms to protect 
confidentiality.
Participant characteristics
The 151 survey participants were young (mean age 28.8; sd 6.2) and 84% male (n=127). The 
majority reported injecting cocaine (76.2%, n=115), followed by brown sugar heroin 
(16.6%, n=25), and white crest heroin (12.6%, n=19). The 29 participants in the qualitative 
component reflect the demographics of our broader survey sample, with the exception that 
we oversampled women due to their heightened health and social vulnerabilities. The 
qualitative sample was 55% male (n=16), the mean age was 26.7 years, and 55% had a high 
school education. The majority reported past month injection of cocaine (66%, n=19), 
followed by brown sugar heroin (31%, n=9) and white crest heroin (10%, n=3). A 
descriptive epidemiological analysis of our sample has been published elsewhere (Syvertsen, 
et al 2015).
Emerging drug markets in Kisumu
We documented a dynamic and chaotic drug market in Kisumu, reflective of the fluid and 
adaptive characteristics typical of new drug markets (Hoffer et al., 2009). While Kisumu’s 
market shares some common features with drug markets elsewhere in the world, other 
dimensions are unique and were unanticipated by the research team. The following 
ethnographic tale first examines the material dimensions of Kisumu’s drug market, including 
perceived availability of heroin and cocaine, questions around drug purity, and reported 
pharmacological effects, before transitioning into a theoretical discussion considering how 
these factors shape and reflect broader social phenomena.
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In conversations on the street and in qualitative interviews, participants named bhang 
(marijuana), brown and white powdered forms of heroin, cocaine, and a variety of 
pharmaceuticals as available in the Nyanza drug market. In contrast to more established 
markets in Mombasa and Nairobi where there is “money and sex” and markets are perceived 
as “out in the open,” the drug market in Kisumu is regarded as comparatively hidden, erratic, 
and expensive. Logistically, this growing but still largely disorganized market is operated by 
small time connections between friends and associates who are “sent” elsewhere in Kenya to 
bring drugs into Kisumu, meaning the supply is sometimes unreliable and the price can shift 
with transportation costs. Prices in Kisumu also depend on the peddler, as many are willing 
to sell smaller amounts at reduced cost, especially if the buyer is a known customer. 
Moreover, several male participants reported trafficking cocaine and heroin from Mombasa 
and Nairobi to Kisumu and even into Uganda, which increased their access to drugs for 
themselves and close associates. Hamza, 31, who first injected heroin in Mombasa and has 
trafficked bhang (marijuana) into Uganda, said the price can fluctuate depending on 
availability, but he can occasionally access it for free when supplying it on behalf of another 
peddler. Injectors also held a common perception that some of the cocaine in western Kenya 
was trafficked through rural southern Nyanza from Tanzania, though no one we spoke with 
claimed direct involvement in these routes.
Nevertheless, with multiple drug trafficking networks broadening their reach, injectors 
described how the availability of drugs in Kisumu has increased over the past several years 
and that substance use has become an issue of growing local importance. According to 
Franny, a 31-year-old woman born in Kisumu:
“When I was growing up, I never used to see people having a ‘blackout’ on the 
road, a lot of drinking sprees. Everywhere there is a wine and spirit place. Young 
kids are sniffing glue. People [are] injecting drugs. It is hard to believe.”
Moses, 26, offered an explanation for the recent proliferation of the drug market in Kisumu, 
suggesting that sociopolitical factors such as the “county thing” -- Kenya’s recent move to 
decentralize government operations and grant each county with greater local governance -- 
facilitates the movement of drugs and new forms of practice (e.g., injection) into outlying 
markets like Kisumu:
“In Kisumu, the injection drug thing is growing. Way back, it was not a lot. For 
now, the way Kisumu is developing, it is kind of growing…The more Kisumu 
grows, many people come from Nairobi. There is this county thing. People go back 
to their county to develop their county. So, it is happening now. Like Nairobi, it 
[injection drug use] started way back. In Kisumu, it is something that is growing.”
A focus on urban and mostly coastal locations even in well studied countries like the U.S. 
has often ignored injection drug use in smaller and rural communities (Young & Havens, 
2012; Young, Havens, & Leukefeld, 2012), yet increased globalization, development, 
migration, and geographically dispersed social connections are important factors shaping 
drug markets and propelling drug use into new areas (Ojeda et al., 2012; Rhodes et al., 1999; 
Rhodes & Bivol, 2012). In Kisumu, many injectors attribute the growing drug market to 
internal migration and socioeconomic development in the region, suggesting that a similar 
phenomenon could be underway elsewhere across sub-Saharan Africa where the social 
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landscape is rapidly changing. Indeed, the small scale operations we documented reflect 
broader regional trends that the majority of drug trafficking is comprised of small, local 
smuggling networks (Carrier & Klantschnig, 2012).
However, we contend that these smaller, newer markets may differ in important ways from 
major trafficking hubs. In contrast to other research in East Africa on white powdered heroin 
markets (Beckerleg & Gillian Lewando Hundt, 2004; Guise et al., 2015; Kurth et al., 2015; 
McCurdy et al., 2006; McCurdy et al., 2005; Rhodes et al., 2015a; Tun et al., 2015; Williams 
et al., 2007), injectors in Kisumu primarily described access to brown heroin. The “brown” 
was typically described as a brown powder, granular, or semi-solid form resembling 
“jaggery,” a concentrated form of sugar cane syrup. More frequent reports of brown sugar 
compared to white heroin may indicate that regional heroin sources are dynamic and shifting 
(Dimova, 2014), bearing direct implications for drug preparation processes and HIV 
transmissibility (Ciccarone, 2005; Koester, Glanz, & Baron, 2005). Indeed, all drug markets 
are dynamic and purity and price shift constantly due to an array of interrelated factors 
(Rosenblum et al., 2014; Werb et al., 2013).
The prevalence of brown sugar heroin in Kisumu could also be explained by adulteration, 
which could change the color and texture of white powder (Dimova 2014). Jabril, 25, said 
that some peddlers have different preparations of brown sugar for sale:
He [the peddler] mixes [it] with another drug; for example, he sells us brown but 
this brown he has soaked it in something you see… a peddler can say this one I 
have already mixed with tap tap [a prescription drug] another one can say this one I 
have mixed with petrol, so the one for this one is not the same as for the other one. 
They [each] have their cocktail that they use.
In all drug markets, dealers typically “cut” drugs with adulterants to further their supply and 
increase profit margins, which often leaves consumers unable to assess drug quality (Harris, 
Forseth, & Rhodes, 2015; Soukup-Baljak, Greer, Amlani, Sampson, & Buxton, 2015). In 
Kisumu, injectors frequently discussed their misgivings about the drugs that reached the 
local market, including their mistrust of peddlers, peddlers who “boost” their products with 
adulterants, and rumors of “fake” drugs in Kisumu. Jackton, 25, said accessing the drugs in 
Kisumu can be a “problem” because of this uncertainty:
You can get it [the drugs] mixed with other things. You must therefore be keen on 
the people that you are approaching. You must have a trusted peddler. You can give 
him money so as to earn his trust. We just survive. You know people must be 
conning as well.
Likewise, Franny noted difficulties in gaining access to trusted sources for drugs: You also 
know that barons are tricky. They will give you anything provided that you remain high. You 
are not supposed to ask about it.
The “barons” – those in higher level positions in the market – as well as peddlers and local 
users themselves are embroiled in sourcing drugs from numerous contacts, creating multiple 
opportunities for adulteration along the supply chain toward Kisumu. As our research 
progressed, we investigated these possibilities by following up with participants who 
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claimed to work in the market. Over the course of several ethnographic interviews with one 
injector who transported heroin from Mombasa to Kisumu, we learned that he delivers “the 
special,” or larger, more expensive sealed bags of product to wealthier consumers, while 
“the local” consisted of smaller amounts of leftover drugs sold at lower cost. Several other 
interviewees and injectors with whom we spoke in the field admitted they knew peddlers 
who adulterated their products to boost profits, but declined to share specifics. Importantly, 
the lack of information on the street about the cut can result in overdose deaths and other 
adverse health outcomes, as evidenced in some U.S. heroin markets (Denton, Donoghue, 
McReynolds, & Kalelkar, 2008; Mars et al., 2015). Low-level users who inject adulterated, 
lower quality, and therefore more dangerous drugs often have less access to public health 
services to contend with the health consequences.
Adulterants may create varied physical effects, and could also help explain an unanticipated 
theme we documented around the duration of injectors’ highs. Qualitative interviews and 
informal conversations with both heroin and cocaine injectors revealed that injectors 
commonly experienced highs lasting from several days to up to one week, thereby obviating 
the need for more frequent injection. When asked about his heroin use, John, 24, explained 
that he was not a daily heroin injector: “No you can’t handle that, you just inject once and it 
is in your system for a whole week, you can just take hot water to increase its effect… you 
can also take a little alcohol, that’s how you go about it.”
The majority of injectors shared this belief that ingesting any hot liquid or food “reactivates” 
or “awakens” one’s high, even days after injecting. According to Baraka: “… when cocaine 
is in the blood system, you don’t need to go and look for it again, you can just drink a hot tea 
or water and you just start feeling high.”
At this point, it remains unclear if participants’ reports of using hot liquids to “reactivate” 
intoxicative effects signal shared cultural expectations of drug use (Becker, 1953) or may be 
an actual physiological reaction to the drugs. One potential explanation is that these drugs 
are boosted with caffeine or potentially other stronger stimulants (Dimova 2014). While 
reports on diversion of pre-cursor chemicals and evidence of methamphetamine 
manufacturing, trafficking, arrests, and seizures in Kenya support this possibility 
(International Narcotics Control Board, 2014; Nation Reporter, 2014; UNODC, 2013a), 
further surveillance and research incorporating chemical testing is needed for confirmation.
Cocaine markets in Kisumu?
Following themes of market chaos, adulteration, and unusual intoxicative experiences, we 
now turn to the most unexpected finding in our study: widespread reports of cocaine 
injection in Kisumu. The majority of participants in the survey (76.1%) and qualitative 
interviews reported to inject cocaine. Outreach activities on the street and other informal 
conversations indicated that a popular discourse on cocaine circulated in Kisumu, though 
injectors had different ideas about its centrality in the local market. Several men and women 
insisted that “only” cocaine was available in the market, while others said it was available, 
but often difficult to access because it is for “rich people.” Baraka, 31, first reported being 
exposed to cocaine in Mombasa, but noted a difference in availability between the markets: 
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“Cocaine is very expensive, brown sugar [heroin] is found locally even in Kisumu, but this 
cocaine is not found in Kisumu. We have to send someone to bring it for us.” Wilson, 29, 
who claims to transit cocaine from Mombasa to Uganda, said that cocaine is difficult for 
most people in Kisumu to afford: “People would wish to use cocaine but I think heroin is 
much cheaper… It is just that there are people who cannot afford cocaine.”
To explore the possibility of cocaine in Kisumu’s market, we looked to our data on drug 
prices for further clues. We anticipated that prices for cocaine would be higher than for 
heroin, but because our survey questions were informed by our formative work identifying 
flexibility in drug selling and the importance of pooling resources to purchase drugs, we 
asked, “On average, when you buy or contribute money to get [specific drugs], how much 
money do you spend?” Survey data indicated participants paid an average of 300 Kenyan 
shillings (range, 200-800) for cocaine, 280 (range, 150-750) for brown sugar heroin, and 250 
(range, 100-500) for white crest heroin (US exchange rates range from 85-100 shillings to 
the dollar). In the qualitative interviews, participants described pooling money to purchase 
drugs at 200-400 Kenyan shillings (US $2-$3) per fingernail (a standard way injectors spoke 
of measuring drugs) or larger amounts for 2,500-4,000 shillings (US $26-43) for either 
heroin or cocaine. Unfortunately, these data do not provide standardized information on 
pricing. However, findings indicate that in the context of poverty, pooling resources enabled 
more people to access drugs, which has been similarly documented in other social contexts 
(Stephen Koester et al., 2005). Ruby, 28, said her group members contribute whatever they 
can for cocaine: “You don’t buy it alone. Everyone wants to use it.”
As our price differentials failed to help explain market differences in availability, we also 
examined the ways in which injectors described their intoxication and found that several 
common pharmacological modes of experience emerged from cocaine injection. Among one 
group, the reported effects of cocaine were akin to heroin, including drowsiness, calmness, 
and feeling sick when going without it. Ruby recounted that she was with a group of four 
women in a rural area for a funeral when they decided to ask male friends to try the cocaine 
they brought with them:
Q: How did you feel when you injected the cocaine?
A: I was weak and tired for the next three days. I couldn’t move an inch. They told 
me to take another dose. They also provided it for free. I couldn’t move for the next 
three days and they gave me another dose. I started purchasing it after some time.
Ruby has continued to inject over the past two years and developed a physical dependence to 
it: “I normally feel awful before injecting it… I will feel good after injecting. I however 
cannot even move my head in case I fail to inject.” Similarly, Norma, 25, was introduced to 
cocaine in Kisumu in 2007 by male friends and has continued using it ever since: “it calms 
me down very much, sometimes I feel very sick if have stayed for long without using it.”
Equally as common as the above symptomology, however, others described cocaine as 
engendering heightened energy, sexual arousal, and a propensity for violence. Kennedy, 23, 
said he often feels “rowdy” and gains a sense of invincibility after injecting cocaine: “You 
can even carry a big bus with your one hand. You can just carry it! (Laughter).”
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Other cocaine injectors described heightened sexual arousal as a primary effect. Leticia, 35, 
was exposed to cocaine by male friends who one day introduced something stronger than the 
usual bhang the group smoked:
Q: Tell me about the first time when you used cocaine. How did they convince you?
A: They told me that they have bought something different from bhang. I asked 
what it was and that is when they disclosed the name as cocaine. They called it 
powder. I was shocked but they told me to wait and experience how the powder can 
be used. That was after I had contributed [money]. They boiled some water. We 
withdrew with a syringe and injected ourselves. It is also dangerous. The challenge 
is on the price. One of you cannot afford it.
Q: What do you mean when you say it is dangerous?
A: I mean it will always force you into sex. You will just want to have sex. It 
increases your libido.
Wilson, 29, who claimed to transit cocaine from Mombasa to Uganda, agreed that 
“obviously you will feel that you need sex after injecting drugs.” He also described other 
indications of hyperactivity and violence associated with cocaine:
I became so talkative. There is that feeling of being so violent. You feel that you 
can talk. You have a point in each and everything that you say. You feel sweet. 
When you over use it, you will think and meditate a lot. What you keep thinking of 
is illusions. What you think of has to happen. It is not easy when I use it. 
Sometimes I don’t sleep. I have a sleeping problem. It makes me active. I will find 
something to read. You will see that I like reading. That is what happens.
Violence was listed by (mostly) male cocaine users as a side effect, including Ricky, 35, who 
said after he injected cocaine, “I felt offended with the slightest provocation or jokes, felt 
like injuring anybody that provoked me slightly.” King, 26, started using cocaine in Nairobi 
in 2009 when he acted as a supplier on behalf of his cousin. In the course of telling several 
stories from his time there of violence, stealing merchandise, and getting shot, he related 
how cocaine accentuated his actions:
Cocaine is like a morale booster - you take it when planning something big. If I 
take cocaine, beating, killing, or raping you will not be a problem to me. I will do it 
with ease even if five people try to counter me, I know they will feel my strength…
Pharmacologically, none of these reported experiences of intoxication match the classic 
short term rush that cocaine typically engenders, leaving unanswered questions about 
cocaine’s availability in the region. Clearly, some of our findings might be explained as a 
misunderstanding. In new drug markets where services and educational resources are 
limited, injectors may lack reliable information about the drugs they are injecting. Women in 
particular may be vulnerable due to an inability to control the circumstances of their 
injection initiation or access to drug preparation and injection processes (Wagner, Jackson 
Bloom, Hathazi, Sanders, & Lankenau, 2013). Again, another possibility is that the reported 
cocaine is actually adulterated heroin (Dimova 2014).
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This would not be the first instance of disagreement over availability of white powdered 
drugs in East Africa, however: when brown heroin shifted to white powdered heroin in the 
1990s, some users and police in Malindi suggested that the new form of heroin was a 
synthetic substance manufactured by university students in Nairobi (Beckerleg & Hundt, 
2004). Others called it cocaine, which created confusion about the availability of cocaine in 
the East African market (Beckerleg & Hundt, 2004; McCurdy & Maruyama, 2013). 
Reflecting these perceptions, global drug surveillance reports documented cocaine use in 
East Africa as early as the 1990s. For example, in 1999, a United Nations Office for Drug 
Control and Crime Prevention report documented that 4.5% of youths (ages 12-18) in Kenya 
had tried cocaine in their lifetime, third only to the Bahamas (6.4%) and USA (6.0%), with 
overall lifetime prevalence among adults reported at 0.1% (UNODCCP, 1999). Such 
statistics are suspect, but speak to a historical sense of chaos and limited understanding of 
drug availability and local use in sub-Saharan Africa (Adelekan & Stimson, 1997). In the 
current study, participants who were interviewed in Swahili and Luo often referred to the 
drug as “cocaine” in English, and sometimes it was simply called powder (unga). It may be 
that cocaine was introduced to Kisumu as a generic term for drugs parallel to other cultural 
contexts where the word “dope” can reference anything from marijuana to heroin. As such, 
some of our findings may reflect local naming conventions rather than accurately describe 
the chemical composition of locally consumed drugs.
Although it is unlikely that cocaine is currently available to the extent that participants in 
Kisumu claim, our findings should not imply its total absence in the Kenyan market. 
Regional prevalence of cocaine use is thought to be relatively limited (UNODC, 2013b) but 
a number of recent seizures suggest that air cargo and shipping containers of cocaine transit 
from South America to Europe via East Africa to take advantage of regional corruption and 
frail law enforcement (International Narcotics Control Board, 2014; UNODC, 2013a). A 
record seizure of 701 kg of cocaine off the Kenyan coast in 2004 (UNODC, 2013a) and 
other recent media reports (Kariuki, 2013; Mwaniki & Angira, 2013) corroborate reports 
from injectors in our study, who referenced cocaine originating from Colombia as available 
on the coast and Nairobi, some of which moves onward toward Kisumu. Participants also 
perceived cocaine to be circulating northbound from western Tanzania, and reported seizures 
of cocaine in Tanzania (UNODC, 2013a) open the possibility to support these perceptions. 
In particular, wealthy Kenyans may have access to cocaine and purer forms of white heroin, 
which we heard unsubstantiated rumors of in certain communities in Kisumu.
Although we are unable to offer concrete evidence of cocaine in Kisumu, our point is that its 
possibility exists and that the uncertainty and tensions in these accounts raise further issues 
of social and policy significance. In terms of policy, we should try to understand more about 
what people think and believe about their drug use, as programs and information campaigns 
targeted towards “heroin” users will miss an important group of people who say that they 
inject “cocaine.” We further suggest that a broader reading of such market trends lends 
insight into the social significance of drugs in society, as explored below.
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The social imagination of injection drug use
Regardless of its actual availability, the idea of cocaine has already imprinted into the 
sociological imagination of East Africa. Rather than dismiss reports of cocaine injection 
entirely, we assert that the chaos of Kisumu’s drug market and widespread beliefs around 
cocaine may tell us something else important about Kenya’s sociopolitical position in the 
world. As Agar and Reislinger (2002) highlight in their development of “trend theory,” drug 
markets are contingent historical processes shaped by both material and affective 
dimensions. They suggest that markets develop alongside a concomitant mix of “hope and 
despair” reflective of widening gaps between individuals’ increasing expectations of 
standards of living with the structural violence that prevents achievements of such goals 
(Agar & Reisinger, 2001). This gap is embodied as frustration, anger, pain, and other 
affective responses that drive drug market demand (Bourgois, 2003; Singer, 2001). Global 
scholarship has documented how structural violence engenders substance use and 
disproportionately configures its harms among disadvantaged groups (Bourgois & 
Schonberg, 2009; Rhodes, Singer, Bourgois, Friedman, & Strathdee, 2005). Beckerleg 
borrowed ideas from structural violence and trend theory to analyze the early heroin crisis in 
coastal Kenya; she questioned the “prosperity” of a tourist economy that created inequalities 
and fueled a local drug trade that has devastated mostly poor, socially marginalized users 
(Beckerleg & Hundt 2004b).
In Kisumu, we heard similar stories about the initiation of drug injection – whether they 
believed it to be cocaine or heroin – as reflective of feelings of alienation from broader 
processes of development and modernization. Participants commonly described injection as 
a way to alleviate stress, boredom, and “idleness.” Drugs filled a void when participants 
were unable to find a job or fit into Kisumu’s growing economic sector or population of 
youth pursuing higher education. Jabril, for example, said that injecting made him forget his 
problems:
The life that I am living, the problems, there is a way if I use it, I don’t have a 
problem but if I become sober, I have a lot of problems so I want to remain high. If 
am high, I am handsome, friendly, and rich, if am sober I remember problems… 
It’s like I am covering my eyes. I mean there are bigger problems exceeding the 
drug.
Such linkages between individual decisions to use drugs and the broader social context came 
across in multiple interviews and were common concerns expressed in conducting street 
outreach. Hamza, 31, described his heroin use in the following way:
You will think of so many things after injecting. You will think that you are now in 
town and jobless. I try looking for a job but end up with nothing. I cannot go to [my 
home] village because I lack money. Those guys whom you went to school with are 
enjoying. But you will let it be - ‘sulu bin sulu’ - after injecting the drug. The days 
will move.
In Swahili, the meaning of sulu bin sulu depends on the context. Here, it refers to numbing 
oneself from circumstances of want or scarcity. Injection makes the days “move” along, 
perhaps for days at a time according to shared cultural understandings around long-lasting 
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highs maintained through ingesting alcohol or hot liquids. In this context, perhaps drug 
injection represents an extended “time out” from such daily struggles.
Although Kenya has been hailed as one of the fastest growing economies in sub-Saharan 
Africa, it continues to face a number of challenges including poverty, high unemployment, 
gender inequality, and security concerns (Odero, Reeves, & Kipyego, 2015). Furthermore, 
the western Nyanza region has historically remained marginalized from political power, less 
economically developed, and unable to shirk stereotypes as cultural outsiders within Kenya 
(Carotenuto & Luongo, 2009; Smith, 2006). Within this broader framework of exclusion, the 
regional HIV epidemic has continued unabated (18.7% prevalence in Kisumu County) and 
enabled a drug market to emerge amidst the “hope and despair” of a new generation whose 
unfulfilled ambitions are numbed with injection.
However, as Fitzgerald points out (2005), analyses of drug markets in contexts outside of 
Western nations tend to take this pathological focus rather than nuanced cultural 
interpretation. Drawing on Taussig’s ideas linking the “magic” of cocaine consumption with 
capitalist desires and new identity formations (Taussig, 2009), Fitzgerald (2005) challenges 
scholars to rethink non-Western drug markets in ways that acknowledge the hopes, dreams, 
and pleasures that drug initiates pursue. Drugs become “magic” or “fetishized” by acquiring 
social meaning beyond their chemical composition (Taussig, 2009).
Indeed, we also identified motivations for drug injection that extended beyond pathology. 
Anthony, 38, tried injecting because “experience is the best teacher” and many other 
participants followed suit, initiating because of a desire to belong to a larger social 
phenomenon. Even if users had little knowledge of these drugs before they were introduced, 
participants were curious and unafraid to try injecting. Robbie, 24, said: “Some friends 
convinced us to inject the drug because it is normally good and makes you high. [They said] 
‘You will be fine when you inject cocaine.’ I used it and it worked.” Similarly, several 
participants described injection as a “morale booster,” or something that made them feel 
positive about themselves and their living situation.
Winnie, 24, told the story of her first time injecting cocaine; one night after getting drunk 
with several male friends, she went home with them, “hoping for more drinks,” but instead 
was introduced to injecting cocaine:
They [the men] signaled each other and then [a friend] told me that I am about to 
get what will keep me drunk 24/7. I inquired to know what exactly that was, though 
I had already gotten an idea of what it was, having watched several movies. 
According to [a friend], what I was being offered was ideal for the kind of stress I 
was undergoing.
While Winnie’s story reflects the common theme of stress as an influence in drug use, her 
introduction to cocaine also invokes hope and excitement attached to a new experience that 
will keep her intoxicated for an extended period of time. Beyond her immediate peer group, 
her expectations were also shaped by depictions of drug use in movies. Similarly, Seth, 24, 
aspired to initiate heroin injection because of friends, but his sentiment hints at broader 
aspirations:
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Some of these friends who injected … belonged to the new generation. I was sure 
that I would be like them once I started injecting their drugs.
Recent studies have described emergent drug markets in transitioning economies as a 
“double edge” of escape from dashed hopes of democracy and a symbol of progress (Rhodes 
& Bivol, 2012). Others have considered how emergent drug markets in post-dictatorships 
have been greeted by an “an explosive mix of naiveté and curiosity” by ambitious youths 
looking for fun and danger (Zoccatelli, 2014). In Kisumu, which is experiencing rapid 
urbanization, expanding educational opportunities, and potential for upward social mobility 
in the context of persistent socioeconomic inequalities, the diffusion of drug injection should 
be understood as part of a similarly paradoxical process. Beyond pathology or 
misinformation, we suggest that widespread reports of “cocaine” injection in particular may 
have additional social meaning attached to it.
Following Taussig (2009), we suggest that in Kisumu, the “magic” of cocaine was conjured 
in a drug-naive context where it has captured the collective imagination of youth with new 
aspirations. We contend that the construction of cocaine in East Africa first originated during 
a particular juncture in history when these still relatively young drug markets shifted toward 
white powdered heroin in the region in the 1990s. Beliefs that this powder was cocaine 
secured East Africa’s connectivity to Western markets and Kenya’s status as a drug 
consuming economy when “cocaine” use was reported in global drug surveillance 
documents (UNODCCP 1999). In the West, cocaine has long been associated with wealth 
and prestige, and in all types of drug markets, drug consumption parallels other forms of 
consumer behavior and expresses specific kinds of taste and lifestyle (Fazio, Hunt, & 
Moloney, 2011; Fitzgerald, 2005). In Kisumu, cocaine is viewed by injectors as something 
for “rich people” that “people wish to use” that has even “shocked” eager new initiates, as 
we detailed in the accounts above. Cocaine has also been referenced in recent Kenyan 
movies as proof that “everything” is available in a modern African city like Nairobi 
(Gritonga, 2012) and such media references may shape local consumers’ ideas about drugs. 
To this end, do the actual chemical compounds and psychotropic effects of this cocaine 
matter? Perhaps cocaine’s symbolism of modernity in the context of Kenya’s growing 
integration into global economy (Miguel, 2008) is something for future ethnographic work 
on regional drug markets to further explore.
IMPLICATIONS FOR RESEARCH AND PRACTICE
Our analysis must be interpreted within the context of our study’s limitations and strengths. 
Our research is relatively new in the region; long-term ethnographic engagement is needed 
to continue building trust and engender a more complete understanding of drug markets and 
patterns of injection drug use in Kisumu. It is hoped that our interim analysis, albeit 
incomplete and ongoing, will ignite discussion among researchers and health policy makers 
on drug markets across sub-Saharan Africa. As a limitation, we do not offer a definitive 
pharmacological answer about the drugs circulating in Kisumu, as we were unprepared to 
test drug samples or conduct urinalysis screening, features which could be built into future 
studies. As a strength, our study offers an ethnographic analysis of the health and social 
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dimensions of an emergent drug market in a rapidly urbanizing region of sub-Saharan Africa 
where drug research is limited.
Lessons from Kenya’s dynamic drug market have implications for research and practice. 
First, we suggest a need for enhanced regional drug surveillance and more attention to the 
diversity of drugs that may be emerging in Kenya and beyond. We have few comparative 
data on drug use from newly developing drug markets in sub-Saharan Africa, where 
similarly chaotic situations may be emerging in parallel to Kisumu’s. Given that the global 
burden of HIV infection remains concentrated in sub-Saharan Africa, we join further calls 
for research to characterize and respond to the contribution of injection drug use to an 
already serious HIV epidemic (Guise et al., 2015; Guise et al., 2015; Mbwambo et al., 2012; 
McCurdy et al., 2007).
Evidence-based drug education in new markets like Kisumu is also needed, including 
reliable information on a variety of drugs and their health effects. The availability – and 
perceptions of availability - of drugs in local markets could also be considered in developing 
appropriate drug treatment programs. Kenya’s recent launch of harm reduction programs 
including needle and syringe exchange and methadone are laudable, particularly given the 
underdevelopment of harm reduction programming in much of sub-Saharan Africa. 
However, offering methadone may hold little promise for injectors who do not believe they 
are using heroin, for those whose symptoms cast doubt on what they are injecting, or for 
those whose poly-drug and alcohol use could increase risk for methadone-related overdose 
death (Rhodes et al., 2015a). If cocaine, methamphetamine, or other synthetic stimulants are 
indeed injected in Kenya, alternative prevention and treatment approaches should be 
considered.
Finally, attention to the broader context, including political economic and social conditions, 
contexts of “hope and despair,” and desires for modernity could be addressed through social 
reforms that reduce inequality, improve standards of living, and address the underlying 
conditions amenable to drug use in the first place. In the process, analyses sensitive to the 
historical and sociocultural context could also help us understand how injectors construct 
and experience drug markets in ways that extend beyond the pathologies projected by the 
West (Fitzgerald, 2005). Indeed, long standing questions about local trafficking routes and 
drug injection practices in sub-Saharan Africa remain in newly emerging markets, but may 
provide key insight into this particular juncture in history.
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Highlights
• Drug markets are expanding throughout sub-Saharan Africa
• Emergent drug markets in Kisumu, Kenya, are dynamic and fueling injection 
drug use
• Injectors report availability of heroin and cocaine in Kisumu
• Availability of cocaine is pharmacologically unconfirmed, but opens up 
questions about the social meanings of drug markets
• Drug surveillance, education, and further ethnographic inquiry are needed in 
emergent drug markets in sub-Saharan Africa
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